Cleared Traditional

Uroview FD II (K180651) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180651 · Pausch Medical GmbH · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2018
Decision
30d
Days
Class 2
Risk

K180651 is an FDA 510(k) clearance for the Uroview FD II. Classified as System, X-ray, Fluoroscopic, Image-intensified (product code JAA), Class II - Special Controls.

Submitted by Pausch Medical GmbH (Erlangen, DE). The FDA issued a Cleared decision on April 12, 2018 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pausch Medical GmbH devices

Submission Details

510(k) Number K180651 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2018
Decision Date April 12, 2018
Days to Decision 30 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAA System, X-ray, Fluoroscopic, Image-intensified
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Emergo Global Consulting, LLC
Oliver Eikenberg

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JAA System, X-ray, Fluoroscopic, Image-intensified

All 80
Devices cleared under the same product code (JAA) and FDA review panel - the closest regulatory comparables to K180651.
CS-series-FP with Optional ROI Accessory CA-100S
K182834 · Omega Medical Imaging, LLC · Mar 2019
SonialVision G4
K190373 · Shimadzu Corporation · Mar 2019
MECALL CLISIS SYSTEMS, Discovery RF180
K173395 · General Medical Merate S.P.A · May 2018
DR 800 with MUSICA Dynamic
K180589 · Agfa Healthcare N.V. · Apr 2018
KALARE
K133553 · Toshiba America Medical Systems, In.C · Jun 2014
INFINIX ANGIO WORKSTATION W/DTS SOFTWARE
K132106 · Toshiba America Medical Systems, In.C · Nov 2013